Etiometry Competitive Intelligence & Landscape

The Etiometry Platform is an end-to-end clinical data software solution that focuses on the collection, analysis, visualization, and archiving of ICU clinical data [Source: https://www.etiometry.com/the-etiometry-platform/]. Key capabilities include Data Aggregation & Visualization, Risk Analytics to identify pathways to poor outcomes, Clinical Pathway Automation to standardize care according to hospital guidelines, and tools for Quality Improvement initiatives and research [Source: https://etiometry.com/]. The platform also features an AI-Assistant for Hemodynamic and Respiratory Management in the ICU [Source: https://etiometry.com/]. It is uniquely designed to support the anticipation and management of dynamic patient conditions, with 11 FDA clearances, including four for physiologic risk algorithms [Source: https://www.etiometry.com/faqs/].

Etiometry's target market primarily includes high-acuity care settings, such as ICUs in academic medical centers and leading children's hospitals [Source: https://www.etiometry.com/about-us/join-our-team/]. The platform is utilized in over 175 ICUs across more than 50 hospitals [Source: https://www.etiometry.com/faqs/]. It has demonstrated significant clinical and economic benefits, including reductions in length of stay (up to 36%), ICU readmissions (up to 41%), and ventilation time (up to 30%) [Source: https://etiometry.com/]. The company continues to expand its clinical evidence base, now with multiple adult studies showing its ability to identify patient-specific risk and support improved resource utilization [Source: https://www.etiometry.com/resources/etiometry-expands-evidence-base-with-new-adult-data-demonstrating-clinical-value-across-critical-care-settings/]. Headquartered in Boston, Etiometry is led by President & CEO Shane Cooke, who joined the company in 2019 [Source: https://www.etiometry.com/about-us/leadership/].

The Etiometry platform's core capabilities include Data Aggregation and Visualization, which provides a holistic view of patient data from various monitoring systems, peripheral devices, and EHRs, accessible at the bedside, remotely, or via a central command center [https://www.etiometry.com/the-etiometry-platform/data-aggregation-and-visualization/]. Its Risk Analytics feature offers insights into common pathways leading to poor outcomes, guiding treatment and anticipating patient deterioration through risk indices developed from over 150 million hours of de-identified patient data [https://www.etiometry.com/the-etiometry-platform/risk-analytics/]. Furthermore, Clinical Pathway Automation standardizes care by automating workflows based on hospital guidelines, enabling efficient escalation and de-escalation of care [https://www.etiometry.com/the-etiometry-platform/clinical-pathway-automation/].

Etiometry also includes a Quality Improvement App (QI App), which drives quality initiatives and research by offering accessible long-term storage and reporting of clinical data [https://www.etiometry.com/the-etiometry-platform/quality-improvement/]. This app revolutionizes the ability to measure adoption, compliance, and outcomes associated with clinical pathways. The platform's effectiveness is underscored by its proven ability to reduce ICU length of stay by up to 36%, decrease ICU readmissions by up to 41%, and shorten ventilation times by up to 30% [https://www.etiometry.com/faqs/]. While specific pricing plans, tiers, and recent pricing changes are not publicly disclosed on the website, Etiometry encourages interested parties to request a demo to explore how its AI-driven clinical intelligence can empower proactive and personalized care decisions [https://www.etiometry.com/clinical-intelligence/, https://www.etiometry.com/wp-content/uploads/2024/06/Etiometry_Overview_Clinical_Highlights-4.pdf].

Etiometry actively recruits individuals with diverse expertise, including clinicians to inform product development and data science experts [etiometry.com/resources/after-record-growth-in-2022-etiometry-paves-way-for-2023-expansion/]. The company values direct clinical experience, as evidenced by a former bedside nurse who, after using the Etiometry platform, joined the team to contribute to the data aggregation and visualization platform she knew intimately [etiometry.com/resources/from-bedside-nurse-and-etiometry-user-to-advocate-and-etiometry-employee/]. This approach highlights a strategic focus on integrating real-world clinical insights into its product development, ensuring its software effectively addresses the needs of high-acuity care settings.

The

The company continued its trajectory of strong financial performance with significant business growth and expansion in 2021, achieving new sales milestones and securing strategic collaborations Leading Intensive Care Clinical Decision-Support Solution Secures New Funding and Inks Strategic Collaborations and Clients to Fuel Expansion. This momentum carried into 2022, which was a landmark year for Etiometry, marked by substantial growth, including its database volume exceeding 150 million hours of de-identified data signals BOSTON, Mass. – January 31, 2023 – Etiometry, the leader in clinical decision-support software for critical care, today provided a glimpse into its 2023 priorities as well as highlights from 2022, which marked a landmark year of growth for the company – including its database volume, which now exceeds 150 million hours of deidentified data signals. These patient-generated data are key to scaling Etiometry’s technology to serve additional populations and inform the company’s risk algorithms, whic.

Looking ahead, Etiometry has highlighted its focus on scalability, innovation, and clinical impact, solidifying its role as an effective tool for improving patient outcomes and economics in critical care. An economic impact analysis in March 2026 projected that healthcare institutions utilizing Etiometry’s AI-driven clinical intelligence platform could realize a greater than 2x ROI in the first year and over $2 million in annual savings Healthcare institutions utilizing Etiometry’s AI-driven clinical intelligence platform could see greater than 2X ROI in the first year and over $2 million in annual savings. This demonstrates the platform's significant value proposition, driven by its ability to reduce ICU length of stay by up to 36%, decrease ICU readmissions by up to 41%, and reduce ventilation time by up to 30% Clinical Intelligence Software for High-Acuity Care Teams | Etiometry. These strong financial indicators and positive economic impact analyses underscore Etiometry's robust financial health and promising future.

Etiometry also maintains a prominent presence at major industry conferences. They will be exhibiting at SCCM Critical Care Congress 2025 in Orlando, FL, from February 23-25, 2025, at Booth #1017 [https://www.etiometry.com/etiometry-at-sccm-critical-care-congress-2025/]. This participation allows them to showcase their cutting-edge solutions for high-risk ICU environments, which empower healthcare teams to enhance patient outcomes and optimize efficiency through data-driven decision-making [https://www.etiometry.com/etiometry-at-sccm-critical-care-congress-2025/].

Beyond conferences, Etiometry contributes to ongoing education through Expert Sessions and webinars. Notable past and upcoming sessions include "Leveraging high-frequency data in the contemporary ICU" on May 21, 2026 [https://www.etiometry.com/resources/leveraging-high-frequency-data-in-the-contemporary-icu/], and "Advancing Cardiogenic Shock Management with AI: Classification and Trajectory Tracking" on May 29, 2026, which was sponsored by the Society of Critical Care Cardiology [https://www.etiometry.com/resources/advancing-cardiogenic-shock-management-with-ai-classification-and-trajectory-tracking/]. Additionally, Etiometry presents research and findings at significant medical events, such as the retrospective analysis on the association between IVCO2 Index implementation and blood gas measurement frequency in NICU patients, presented at PAS 2026 [https://www.etiometry.com/resources/pas-2026-abstract-reports-association-between-ivco2-index-implementation-and-blood-gas-measurement-frequency-in-nicu-patients/]. These diverse engagements highlight Etiometry's dedication to sharing knowledge and fostering advancements in critical care.